The “Holy Grail” Regeneration Gene That Helps Limbs Grow Back

Key takeaways

• Scientists identified two “regeneration switch” genes, SP6 and SP8, that turn on in animals capable of regrowing complex tissues.

• Blocking these genes in axolotls and mice disrupts limb and digit regrowth, while a targeted gene therapy can partially restore bone growth in mice.

• Human limb regrowth is still far off, but the shared genetic program across species offers a realistic blueprint for future regenerative therapies.

Nature’s limb regrowers share a genetic code

For decades, scientists have marveled at animals that can regrow lost body parts: salamanders that rebuild whole limbs, zebrafish that restore sliced fins, and even mammals like mice that can regrow the tips of their digits. Behind those “superpowers,” researchers suspected there might be a shared genetic program—a kind of regeneration code.

In a new study, teams working on axolotls, zebrafish, and mice joined forces to look for that code. They focused on the regenerating epidermis, the special wound-covering skin that forms after an amputation and helps orchestrate the rebuilding process. Across all three species, the same pair of genes—SP6 and SP8—lit up in this regenerative skin, flagging them as key players in limb and fin regrowth.

Meet SP6 and SP8: regeneration “switch” genes

SP6 and SP8 belong to a family of genes that help control how tissues form and pattern themselves during development. In these regeneration models, they appear to be repurposed in adulthood to help rebuild complex structures after injury.

In axolotls, which can regrow entire limbs along with parts of the heart, brain, and other organs, SP8 activity was especially prominent. When researchers used CRISPR gene editing to remove SP8 from the axolotl genome, the animals could no longer properly regenerate limb bones after amputation. Instead of forming a fully patterned new limb, the regrowth stalled or produced malformed structures, showing that SP8 is not just a bystander—it is required for proper limb rebuilding.

CRISPR and gene therapy reveal how vital these genes are

The story was similar, though more modest, in mice. Mice cannot regrow full limbs, but they can regenerate the tips of their digits under the right conditions. When SP6 and SP8 were missing from regenerating mouse digits, bone regrowth was impaired. The natural regenerative process that normally knits tissue and bone back together was weakened or failed altogether.

Using that insight, researchers designed a gene therapy strategy. Drawing on previous work in zebrafish, they used a viral vector to deliver FGF8, a signaling molecule that SP8 normally helps turn on. When this therapy was applied to injured mouse digits lacking SP genes, it partially rescued bone regeneration. The digits did not regrow like a salamander limb, but the treatment restored some of the regenerative capacity that had been lost—important proof that missing signals can be reintroduced to nudge tissues toward regrowth.

What this could mean for future human limb repair

Humans cannot spontaneously regrow arms or legs, and no one is suggesting that a single gene therapy is about to change that. Regenerating a human limb would require rebuilding bone, muscle, nerves, blood vessels, skin, and joints in a precisely coordinated way. That is an enormously complex challenge.

However, this study shows that limb and fin regeneration across very different species is driven, in part, by a shared set of genes and signals. That makes regeneration feel less like science fiction and more like advanced biology: a program that evolution has written in multiple animals, and that might still be partially present—but dormant or incomplete—in mammals like us. Future therapies might aim to recreate a “regenerative epidermis” at an injury site by activating SP genes or delivering their downstream signals, in combination with stem cells, biomaterials, and other approaches.

For people who have lost limbs or digits due to injury, vascular disease, or cancer, the long-term vision is profound: instead of relying only on prosthetics or transplants, doctors might one day be able to trigger controlled regrowth of at least some structures. The path from axolotl tanks and mouse labs to human therapies will be long and cautious, but this shared regeneration gene program offers a concrete starting map.

References:

1. David A. Brown, Katja K. Koll, Erin Brush, Grant Darner, Timothy Curtis, Thomas Dvergsten, Melissa Tran, Colleen Milligan, David W. Wolfson, Trevor J. Gonzalez, Sydney Jeffs, Alyssa Ehrhardt, Rochelle Bitolas, Madeleine Landau, Kendall Reitz, David S. Salven, Leslie A. Slota-Burtt, Isabel Snee, Elena Singer-Freeman, Sayuri Bhatia, Jianhong Ou, Aravind Asokan, Joshua D. Currie, Kenneth D. Poss. Enhancer-directed gene delivery for digit regeneration based on conserved epidermal factors. Proceedings of the National Academy of Sciences, 2026; 123 (17) DOI: 10.1073/pnas.2532804123